Platelet function in acute myocardial infarction treated with direct angioplasty

Circulation

Volumn 93, Issue 2, 1996, Pages 229-237

  Gawaz, Meinrad ^a,b   Neumann, Franz Josef ^a   Ott, Ilka ^a   Schiessler, Alexander ^a   Schömig, Albert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

angioplasty; myocardial infarction; platelets; revascularization; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR; MONOCLONAL ANTIBODY; PADGEM PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; UMBILICAL VEIN;

EID: 0030053912     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.2.229     Document Type: Article

References (60)

1. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rate? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation. 1995; 91:476-485.
2. Gibbons RJ, Holmes DR, Reeder GS, Bailey KB, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685-691.
3. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, Vlietstra RE, Strzelecki M, Puchrowicz-Ochocki S, O'Neill WW. Primary angioplasty in myocardial infarction study group: a comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673-679.
4. Zjistra F, Jan de Boer M, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680-684.
5. Uren NG, Crake T, Lefroy DC, DeSilva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med. 1994;331: 222-227.
6. Chen LY, Nichols WW, Hendricks JB, Yang BC, Metha JL. Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc Res. 1994;28:1414-1422.
7. Metha P, Metha J. Platelet function studies in coronary artery disease: evidence for enhanced platelet microthrombus formation activity in acute myocardial infarction. Am J Cardiol. 1979;43: 757-760.
8. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med. 1986;315:983-989.
9. Frink RJ, Rooney PA, Trowbridge JO, Rose JP. Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction. Br Heart J. 1988;59:196-200.
10. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into pathogenesis of acute ischemic syndromes. Circulation. 1988;77:1213-1220.
11. Hirsh J. Hyperreactive platelets and complications of coronary artery disease. N Engl J Med. 1989;316:1543-1544.
12. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation. 1989;80:198-205.
13. Trip MD, Cats VM, VanCapelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990;322:1549-1554.
14. Ruggeri ZM. New insights into mechanisms of platelet adhesion and aggregation. Semin Hematol. 1994;31:229-239.
15. George JN, Nurden AT, Phillips DR. Molecular defects in interactions of platelets with the vessel wall. N Engl J Med. 1984;311: 1084-1098.
16. McEver RP. The clinical significance of platelet membrane glycoproteins. Hematol Oncol Clin North Am. 1990;4:87-103.
17. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood. 1988;71:831-843.
18. Plow EF, Ginsberg MH. Cellular adhesion: GPIIb-IIIa as a prototypic adhesion receptor. In: Coller BS, ed. Progress in Hemostasis and Thrombosis. Philadelphia, Pa: WB Saunders; 1989:117-156.
19. Gawaz MP, Loftus JC, Baijt ML, Frojmovic MM, Plow EF, Ginsberg MH. Ligand binding mediates integrin aIIbb3 (glycoprotein GPIIb-IIIa) dependent homotypic and heterotypic cell-cell interaction. J Clin Invest. 1991;88:1128-1134.
20. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane: studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem. 1989;264: 17049-17057.
21. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelet and platelet-derived microparticles. Blood. 1990;75:128-138.
22. Fox JEB. Shedding of adhesion receptors from the surface of activated platelets. Blood Coagul Fibrinol. 1994;5:291-304.
23. Kelton JG, Warkentin TE, Hayward PM, Murphy WG, Moore JC. Calpain activity with thrombotic thrombocytopenia purpura is associated with platelet microparticles. Blood. 1992;80:2246-2251.
24. Lee YJ, Jy W, Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res. 1993;72: 295-304.
25. Fitzgerald DJ, Catella F, Roy L, Fitzgerald GA. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 1988;1:142-150.
26. 2 modulate the response to tissue-type plasminogen activator in vivo. Circ Res. 1989;65:83-94.
27. Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ. Werdan K. Severity of multiple organ failure but not of sepsis correlates with irreversible platelet degranulation. Infection. 1995;1:16-23.
28. Gawaz MP, Dobos G, Späth M, Schollmeyer P, Gurland HJ, Mujais SK. Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease. J Am Soc Nephrol. 1994;5:36-46.
29. Gawaz MP, Mujais SK, Schmidt B, Gurland HJ. Platelet-leukocyte aggregation during hemodialysis. Kidney Int. 1994;46:489-495.
30. Gawaz M, Ott I, Reininger AJ, Neumann FJ. Effects of magnesium on platelet aggregation and adhesion: magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost. 1994;72:912-918.
31. Ginsberg MH, Frelinger AL, Lam SCT, Forsyth J, McMillan R, Plow EF, Shattil SJ. Analysis of platelet aggregation disorders based on flow cytometric analysis of platelet membrane glycoprotein IIb-IIIa with conformation specific monoclonal antibodies. Blood. 1990;76:2017-2023.
32. Gawaz M, Mayinger P, Neumann FJ. Effects of ATP on ligand recognition of platelet fibrinogen receptor on GPIIb-IIIa. Am J Physiol. 1994;267:H1098-H1106.
33. Jaffe EA, Nachman RL, Becker CG, Minich CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 1973;52: 2745-2752.
34. Rinder HM, Murphy M, Mitchell J, Stocks J, Hillman R, Ault KA. Progressive platelet activation with storage: evidence for shortened survival of activated platelets following transfusion. Transfusion. 1991;31:409-414.
35. Groves HM, Kiniough-Rathbone RL, Mustard JF. Development of non-thrombogenicity of injured rabbit aortas despite inhibition of platelet adherence. Atherosclerosis. 1986;6:189-195.
36. Kristensen SD, Martin JF. Platelet heterogeneity and coronary artery thrombosis. Platelets. 1991;2:11-17.
37. Neumann FJ, Ott I, Gawaz M, Richardt G, Jochum M, Holzapfel H, Schömig A. Cardiac release of cytokines and inflammatory responses during reperfusion in acute myocardial infarction. Circulation. 1995;92:748-775.
38. Oswald GA, Smith CCT, Betteridge DJ, Yudkin JS. Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J. 1988;59:663-671.
39. Hjemdahl P, Chronos NAF, Wilson DJ, Bouloux P, Goodall AH. Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression. Arterioscler Thromb. 1994;14:77-84.
40. Siess W. Molecular mechanisms of platelet activation. Physiol Rev. 1989;69:50-78.
41. Srivastra R, Srimal RC. Amplification of platelet response during acute inflammation in rats. Biochem Pharmacol. 1990;40:357-363.
42. Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller GJ. Epidemiological characteristics of platelet aggregability. Br Med J. 1985;290:428-432.
43. Oleksowicz L, Mrowiec Z, Zuckerman D, Isaacs R, Dutcher J, Puszkin E. Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism. Thromb Haemost. 1994;72:302-308.
44. Lüscher TF. The endothelium and cardiovascular disease: a complex relation. N Engl J Med. 1994;15:1081-1083.
45. Meredith IT, Yeung AC, Weidinger FF, Anderson TJ, Uehata A, Ryan TJ, Selwyn AP, Ganz P. Role of impaired endothelium-dependent vasodilation in ischemic manifestations of coronary artery disease. Circulation. 1993;87(suppl V):V-56-V-66.
46. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981; 304:685-691.
47. 2 and serotonin are possible mediators. Circulation. 1989;79:154-166.
48. Thaulow E, Erikssen J, Sandvik L, Stromorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991;84:613-617.
49. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848-851.
50. Smith JB, Mills DCB. Chemical agents that inhibit platelet aggregation. In: Fisher JW, ed. Biochemical Pharmacology of Blood and Blood-Forming Organs. Heidelberg, Germany/New York, New York: Springer-Verlag; 1992:353-375.
51. Anderson HV, Willerson JT. Thrombolysis in acute myocardial infarction. N Engl J Med. 1993;10:703-709.
52. Harker LA. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol. 1987;60:20B-28B.
53. Scharf RE, Tomer A, Mrzec UM, Teirstein PS, Ruggeri ZM, Harker L. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries: flow cytometric detection. Arterioscler Thromb. 1992;12:1475-1487.
54. Tschoepe D, Schultheiß HP, Kolarov P, Schwippert B, Dannehl K, Nieuwenhuis HK, Kehrel B, Strauer B, Gries FA. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation. 1993;88:37-42.
55. Nurden AT, Macchi L, Bihour C, Durrieu C, Besse P, Nurden P. Markers of platelet activation in coronary hearts disease patients. Eur J Clin Invest. 1994;24:42-45.
56. Langford EJ, Brown AS, Wainwright RJ, deBelder AJ, Thomas MR, Smith REA, Radomski MW, Martin JF, Moncada S. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet. 1994;2:1458-1460.
57. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
58. Hofmann D, Hamm CW, Lorenz RL, Terres W, Weber PC. Evidence for sustained platelet activation in patients with early postinfarction angina. Thromb Res. 1993;72:139-143.
59. George JN, Pickett EB, Saucerman S, McEver RP, Kunicki TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins. J Clin Invest. 1986;78:340-348.
60. Gemmell CH, Sefton MV, Yeo EL. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa: inhibition by RGDS and a Glanzmann's thrombasthenia defect. J Biol Chem. 1993;268: 14586-14589.